TY - JOUR AU - Geddes, R. AU - Knight, S. AU - Moosa, M. Y. S. AU - Reddi, A. AU - Uebel, K. AU - Sunpath, H. PY - 2006 DA - 2006// TI - A high incidence of nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis in HIV-infected patients in a South African context JO - S Afr Med J VL - 96 ID - Geddes2006 ER - TY - JOUR AU - Stead, D. AU - Osler, M. AU - Boulle, A. AU - Rebe, K. AU - Meintjes, G. PY - 2008 DA - 2008// TI - Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa JO - Antivir Ther VL - 13 ID - Stead2008 ER - TY - JOUR AU - Bolhaar, M. G. AU - Karstaedt, A. S. PY - 2007 DA - 2007// TI - A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa JO - Clin Infect Dis VL - 45 UR - https://doi.org/10.1086/518976 DO - 10.1086/518976 ID - Bolhaar2007 ER - TY - JOUR AU - Songa, P. M. AU - Castelnuovo, B. AU - Mugasha, E. B. AU - Ocama, P. AU - Kambugu, A. PY - 2007 DA - 2007// TI - Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda) JO - Clin Infect Dis VL - 45 UR - https://doi.org/10.1086/520023 DO - 10.1086/520023 ID - Songa2007 ER - TY - JOUR AU - Wester, C. W. AU - Okezie, O. A. AU - Thomas, A. M. AU - Bussmann, H. AU - Moyo, S. AU - Muzenda, T. AU - Makhema, J. AU - van Widenfelt, E. AU - Musonda, R. AU - Novitsky, V. AU - Gaolathe, T. AU - Ndwapi, N. AU - Essex, M. AU - Kuritzkes, D. R. AU - deGrutolla, V. AU - Marlink, R. G. PY - 2007 DA - 2007// TI - Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial JO - J Acquir Immune Defic Syndr VL - 46 UR - https://doi.org/10.1097/QAI.0b013e3181568e3f DO - 10.1097/QAI.0b013e3181568e3f ID - Wester2007 ER - TY - JOUR AU - Fabian, J. AU - Venter, W. D. F. AU - Mkhabela, L. AU - Levin, J. B. AU - Baker, L. AU - Naicker, S. PY - 2008 DA - 2008// TI - Symptomatic hyperlactataemia in adults on antiretroviral therapy: a single-centre experience JO - S Afr Med J VL - 98 ID - Fabian2008 ER - TY - JOUR AU - Manosuthi, W. AU - Prasithsirikul, W. AU - Chumpathat, N. AU - Suntisuklappon, B. AU - Athichathanabadi, C. AU - Chimsuntorn, S. AU - Sungkanuparph, S. PY - 2008 DA - 2008// TI - Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting JO - Int J Infect Dis VL - 12 UR - https://doi.org/10.1016/j.ijid.2007.12.005 DO - 10.1016/j.ijid.2007.12.005 ID - Manosuthi2008 ER - TY - CHAP PY - 2006 DA - 2006// BT - Guidelines for prevention, diagnosis and management of NRTI-associated symptomatic hyperlactataemia and lactic acidosis PB - Southern African Journal of HIV Medicine CY - South Africa ID - ref8 ER - TY - JOUR AU - Boulle, A. AU - Orrel, C. AU - Kaplan, R. AU - Van Cutsem, G. AU - McNally, M. AU - Hilderbrand, K. AU - Myer, L. AU - Egger, M. AU - Coetzee, D. AU - Maartens, G. AU - Wood, R. PY - 2007 DA - 2007// TI - Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort JO - Antivir Ther VL - 12 ID - Boulle2007 ER - TY - JOUR AU - Osler, M. AU - Stead, D. AU - Rebe, K. AU - Meintjes, G. AU - Boulle, A. PY - 2010 DA - 2010// TI - Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study JO - HIV Medicine VL - 11 UR - https://doi.org/10.1111/j.1468-1293.2009.00754.x DO - 10.1111/j.1468-1293.2009.00754.x ID - Osler2010 ER - TY - JOUR AU - Hill, A. AU - Ruxrungtham, K. AU - Hanvanich, M. AU - Katlama, C. AU - Wolf, E. AU - Soriano, V. AU - Milinkovic, A. AU - Gatell, J. AU - Ribera, E. PY - 2007 DA - 2007// TI - Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment JO - Expert Opin Pharmacother VL - 8 UR - https://doi.org/10.1517/14656566.8.5.679 DO - 10.1517/14656566.8.5.679 ID - Hill2007 ER - TY - JOUR AU - Pérez, E. H. AU - Dawood, H. AU - Chetty, U. AU - Esterhuizen, T. M. AU - Bizaare, M. PY - 2008 DA - 2008// TI - Validation of the Accutrend® lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting JO - International Journal of Infectious Diseases VL - 12 UR - https://doi.org/10.1016/j.ijid.2008.03.007 DO - 10.1016/j.ijid.2008.03.007 ID - Pérez2008 ER - TY - JOUR AU - Bekker, L. G. AU - Orrell, C. AU - Reader, L. AU - Matoti, K. AU - Cohen, K. AU - Martell, R. AU - Abdullah, F. AU - Wood, R. PY - 2003 DA - 2003// TI - Antiretroviral therapy in a community clinic-early lessons from a pilot project JO - S Afr Med J VL - 93 ID - Bekker2003 ER - TY - JOUR AU - Coetzee, D. AU - Hildebrand, K. AU - Boulle, A. AU - Maartens, G. AU - Louis, F. AU - Labatala, V. AU - Reuter, H. AU - Ntwana, N. AU - Goemaere, E. PY - 2004 DA - 2004// TI - Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa JO - AIDS VL - 18 UR - https://doi.org/10.1097/00002030-200404090-00006 DO - 10.1097/00002030-200404090-00006 ID - Coetzee2004 ER - TY - JOUR AU - Boulle, A. AU - Bock, P. AU - Osler, M. AU - Cohen, K. AU - Channing, L. AU - Hilderbrand, K. AU - Mothibi, E. AU - Zweigenthal, V. AU - Slingers, N. AU - Cloete, K. AU - Abdullah, F. PY - 2008 DA - 2008// TI - Antiretroviral therapy and early mortality in South Africa JO - Bull World Health Organ VL - 86 UR - https://doi.org/10.2471/BLT.07.045294 DO - 10.2471/BLT.07.045294 ID - Boulle2008 ER - TY - CHAP PY - 2004 DA - 2004// TI - National Antiretroviral Treatment Guidelines BT - Jacana ID - ref16 ER - TY - JOUR AU - Westreich, D. J. AU - Sanne, I. AU - Maskew, M. AU - Malope-Kgokong, B. AU - Conradie, F. AU - Majuba, P. AU - Funk, M. J. AU - Kaufman, J. S. AU - Van Rie, A. AU - Macphail, P. PY - 2009 DA - 2009// TI - Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy JO - Clin Infect Dis VL - 48 UR - https://doi.org/10.1086/598977 DO - 10.1086/598977 ID - Westreich2009 ER -